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Summary. Background: Particulate matter (PM) exposure has
been linked to increased risk of cardiovascular disease, possibly
resulting from hypercoagulability and thrombosis. Lung and
systemic inﬂammation resulting from PM inhalation may
activate blood coagulation, but mechanisms for PM-related
hypercoagulability are still largely unknown. Objectives: To
identify coagulation mechanisms activated by PM in a
population with well-characterized exposure. Methods: We
measured prothrombin time (PT), activated partial thrombo-
plastin time, endogenous thrombin potentials (ETPs) with/
without exogenous triggers and with/without soluble thrombo-
modulin, tissue-type plasminogen activator (t-PA) antigen, D-
dimer and C-reactive protein (CRP) in 37 workers in a steel
production plant with well-characterized exposure to PM with
aerodynamic diameter of < 1 lm (PM1) and coarse PM
(PM10 – PM1). Blood samples were collected from each subject
on the ﬁrst (baseline) and last (postexposure) day of a 4-day
work week. We analyzed diﬀerences between baseline and
postexposure levels using a paired Students t-test. We ﬁtted
multivariate mixed-regression models to estimate the associa-
tions of interquartile range PM1 and coarse PM exposure with
parameter levels. Results: None of the parameters showed any
signiﬁcant changes from baseline in postexposure samples.
However, exposure levels were associated with shorter PT
(b[PM1] = )0.33 s, P = 0.08; b[PMcoarse] = ) 0.33 s, P =
0.01), and higher ETP without exogenous triggers and with
thrombomodulin (b[PM1] = + 99 nM min, P = 0.02;
b[PMcoarse] = + 66 nM min, P = 0.05), t-PA (b[PM1] =
+ 0.72 ng mL)1, P = 0.01; b[PMcoarse] = + 0.88 ng mL
)1,
P = 0.04), and CRP (b[PM1] = + 0.59 mg L
)1, P = 0.03;
b[PMcoarse] = + 0.48 mg L
)1, P = 0.01). Conclusions: PM
exposure did not show any short-term eﬀect within the week of
the study. The association of PM exposure with PT, ETP and
CRP provides some evidence of long-term eﬀects on inﬂam-
mation and coagulation.
Keywords: coagulation, endogenous thrombin potential, envi-
ronmental risk factors, occupational health, particulate matter.
Introduction
Epidemiologic studies have linked exposure to particulate
matter (PM) in urban environments with increased morbidity
and mortality from cardiovascular disease [1–4]. PM metal
components have been shown to play important roles in
determining PM-related cardiovascular effects [5]. The under-
lyingmechanisms linking the inhalation of ambient air particles
to cardiovascular diseases are not completely understood [3],
but inﬂammation and hypercoagulability have been indicated
as primary mediators [6].
Seaton et al. [7] ﬁrst hypothesized that inhalation of PM
into the lungs would lead to local alveolar and systemic
inﬂammation, followed by hypercoagulability and increased
risk of thrombotic events. Previous investigations have
demonstrated that levels of coagulation factors such as
factor VIII and ﬁbrinogen, which form part of the acute-
phase responses mediated by cytokines released during
inﬂammatory reactions, increase in association with PM
exposure in humans [8–10]. In a study conducted in Italy, we
recently showed that PM ambient levels were associated with
shortened prothrombin time (PT) in healthy subjects [11] and
patients with deep vein thrombosis [2], a ﬁnding that is
substantiated by evidence from animal models of PM
exposure [12]. However, the ﬁnding of a PM-related shorten-
ing of PT has not yet been evaluated in subsequent human
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studies, and other epidemiologic investigations measuring
individual coagulation factors failed to produce consistent
results [13–16].
During inﬂammatory conditions, reactive oxygen species
and inﬂammatory mediators, including C-reactive protein
(CRP), stimulate the production of tissue factor [17], a
primary initiator of in vivo coagulation [17,18]. The thrombin
generation test is a global functional assay that describes
overall coagulability and represents the time course of
formation and decay of thrombin, the key enzyme in clot
formation [19,20], in response to triggering by tissue factor.
Thrombin generation decreases in patient with anticoagulant
treatment [21], increases in patients with thrombophilia [22],
and has been recently been correlated with higher risk of
thromboembolism [23].
Previous studies on PM effects have usually investigated
blood coagulation in heterogeneous study groups in relation to
exposure levels that have often been estimated using outdoor
measurements from monitoring stations located at variable
distances from the residence of the study participants.
Variations of exposure due to daily activities, including
work-related activities, have not usually been considered in
these analyses. Work conditions may cause exposure to indoor
PM levels that are considerably higher than outdoor concen-
trations. In industrial settings, workers are usually assigned to
speciﬁc job tasks that tend to be repeated regularly over time.
Differences in work routines may thus determine wide and
stable gradients of individual exposure to particles, even
among workers in the same work facility. Steel workers are
exposed to high levels of metal-rich air particles, and are at
higher risk for cardiovascular disease [24]. In the present study,
we investigated a group of steel workers exposed to a wide
range of PM levels, in order to identify inﬂammation-
dependent alterations in blood coagulation using functional
global tests, as well as measures of individual hemostatic and
inﬂammatory components.
Materials and methods
Study subjects
We recruited, in a steel production plant in Brescia, northern
Italy, two complete teams of shift workers free of cancer and
cardiopulmonary disease, giving a total of 37 male subjects.
All participants had been working in the current job position
for at least 1 year. All of them had a rotating weekly
schedule based on four consecutive working days of 8 h
each, followed by 2 days of rest. In order to discriminate
short-term and long-term effects of PM, we obtained blood
samples for coagulation and other biomarkers at two
different times: (i) the time 1 sample was collected on the
morning of the ﬁrst day of a working week (following 2 days
off work) before the beginning of any work activity; and (ii)
the time 2 sample was collected at the same hour on the
fourth day of work, following three consecutive days of
work.
A self-administered questionnaire was used to collect
detailed information on lifestyle, drug use, medical conditions,
body mass index (BMI), education, and residential history.
Records from the factory administrative ﬁles were used to
obtain information on occupational history. Individual written
informed consent and approval from the local Institutional
Review Board were obtained before the study.
Exposure assessment
Measures of PM with aerodynamic diameters of < 10 lm
(PM10) and < 1 lm (PM1), obtained in each of the 11 work
areas of the steel production plant, were used to estimate
individual exposures. PM10 and PM1weremeasured during the
days between time 1 and time 2, using a GRIMM 1100 light-
scattering dust analyzer (Grimm Technologies, Douglasville,
GA, USA). The fractions considered for this study were PM1
and coarse particles, deﬁned as the difference between PM10
and PM1 [25]. During the three working days between time 1
and time 2, each of the study subjects recorded the time spent
in each of the work areas in a personal log. Individual exposure
was calculated as the average of area-speciﬁc PM levels
weighted by the time spent in each area. PM levels in each of
the work areas have shown very little variability over time, as
measures repeated over 1 year showed very high correlation
(r2 > 0.90). Because all of the study subjects reported in the
questionnaire that they had performed their standard work
routine during the 3 days of the study, the time-weighted PM1
and coarse PM concentrations also represented a measure of
their usual exposure.
Laboratory methods
Blood for coagulation testing was drawn into vacuum tubes
(Becton Dickinson, Meylan, France) containing 0.109 M
trisodium citrate at a ratio of 9 : 1 (blood/anticoagulant).
PT was measured with human relipidated recombinant
thromboplastin (Recombiplastin, InstrumentationLaboratory,
Orangeburg,NY,USA) in combination with a fully automated
photo-optical coagulometer (ACL; Instrumentation Labora-
tory, Lexington, MA, USA). The activated partial thrombo-
plastin time (APTT) was measured with ‘‘Automated-APTT’’
(bioMerieux, Durham, NC, USA), using an ACL coagulome-
ter (Instrumentation Laboratory). PT and APTT were
expressed as clotting times in seconds.
Tissue-type plasminogen activator (t-PA), D-dimer and C-
reactive protein (CRP) were determined using commercially
available enzyme-linked immunosorbent assay (ELISA) assays
(ELISA-Zymutest; HYPHEN BioMed, Neuville-Sur-Oise,
France). Thrombin generation was assessed according to
Hemker et al. [20], as described by Chantarankgkul et al.
[26]. The test was based on the activation of coagulation in
platelet-poor plasma with calcium chloride, with or without
tissue factor and phospholipids as exogenous triggers of blood
coagulation. The composition of the phospholipid mixture was
as follows: 1,2-dioleoyl-sn-glycero-3-phosphoserine, 1,2-diol-
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eoyl-sn-glycero-3-phosphoethanolamine, and 1,2-dioleoyl-sn-
glycero-3-phosphocholine (Avanti Polar Lipids Inc., Alabaster,
AL, USA), in a molar ratio of 20 : 20 : 60. The tissue factor
(Recombiplastin; Instrumention Laboratory) and phospho-
lipid concentrations, when they were included in the test
system, were 1 pM and 1 lM, respectively. Testing was also
performed in the presence of soluble rabbit thrombomodulin
(ICN Biomedicals, Aurora, OH, USA) as activator of
protein C, added to the reaction mixture at a ﬁnal concentra-
tion of 4 nM. Continuous registration of the generated
thrombin was achieved with a ﬂuorogenic synthetic sub-
strate (Z-Gly-Gly-Arg-AMC-HCl; Bachem, AG, Bubendorf,
Switzerland) added to the test system at a ﬁnal concentration of
417 lM. The procedure was carried out with an automated
ﬂuorometer (Fluoroskan Ascent; ThermoLabsystem, Helsinki,
Finland). Readings from the ﬂuorometer were automatically
recorded and analyzed with dedicated software (THROMBINO-
SCOPE; Thrombinoscope BV, Maastricht, The Netherlands),
which displays thrombin generation curves [nM thrombin vs.
time (min)] and calculates the area under the curve, deﬁned as
endogenous thrombin potential (ETP) and expressed as nM
thrombin · minutes (nM min). Thrombin generation is mea-
sured as function of an internal calibrator for thrombin
(Thrombin Calibrator; Thrombinoscope BV). ETP represents
the plasma balance between the action of procoagulants and
that of anticoagulants.
Statistical analysis
We investigated the relationship of PM exposure to inﬂam-
mation and coagulation markers to identify transient and
permanent effects. Transient effects were evaluated bymeans of
paired Students t-tests that compared inﬂammation and
coagulation markers (outcome measures) measured on the
ﬁrst day of a working week (time 1, following 2 days off work)
with those thosemeasured after three consecutive working days
(time 2) of the same week. In this analysis, we aimed at
identifying rapid changes associated with the 3-day exposure
occurring between time 1 and time 2. We also used multivar-
iate regression models that included as the dependent variable
the difference in individual outcome measures between the two
time points (time 2 – time 1), and as independent variables
PM1 or coarse PM levels, as well as covariates for potential
confounders, including age (continuous), education (primary,
secondary, or college), BMI (continuous), current smoking
(yes/no), and use of non-steroidal anti-inﬂammatory drugs
(NSAIDs) in the 7 days before the examination (yes/no).
We also evaluated, for each of the outcome measures
investigated, the effect of particle exposure levels regardless of
whether the outcome measures were measured at time 1 or
time 2. This set of analyses was performed using multivariate
mixed-effectmodels to account for within-subject correlation in
repeated measures, and was based on the following assump-
tions, as previously described [27]: (i) the exposure measured
during the study reﬂected a gradient of exposure among the
workers examined that did not have major variations over
time; and (ii) the effects of particles identiﬁed in these analyses
were permanent, that is, had equal associations with the
outcomes at time 1 and time 2. The two assumptions were
considered to be valid on the basis of the following ﬁndings: (i)
high correlation of particle levels that were repeatedly mea-
sured in each of the 11 work areas during a 1-year period, as
described above; (ii) no variation of the job tasks assigned to
each of the study participants in the year before the study; and
(iii) for those exposures that showed signiﬁcant associations in
the mixed-model analysis, the associations with outcomes at
time 1 and time 2 were similar (P > 0.05 for interaction term
between exposure and time).
In mixed-regressionmodels, we included the same covariates
as in the analysis of transient effects, that is, age, education,
BMI, current smoking, and NSAID use in the last 7 days. To
allow for comparison of the size of effects of PM1 and coarse
PM, we report all model results as regression coefﬁcients (b)
estimating the change in the outcome measure due to an
increment in exposure equal to the difference between the 75th
and 25th centiles (interquartile range). A two-sided P-value of
< 0.05 was considered to be statistically signiﬁcant. Data were
analyzed using STATA (Version 10.0; Stata Corp., College
Station, TX, USA).
Results
The general characteristics of the study participants are shown
in Table 1. Study subjects were found to be exposed to average
PM levels up to ﬁve times higher than the levels of action used
for the general population (50 lg m)3 for PM10, EU direc-
tive 50/2008), with a wide gradient of exposures (Table 2). As
expected, individual exposures to PM1 and coarse PM were
highly correlated with each other (Pearsons coefﬁcient
r = 0.94, P < 0.001).
Inﬂammation, blood coagulation and ﬁbrinolysis markers
measured at time 1 and time 2 are shown in Table 3. No
signiﬁcant differences were found between the two time points
in PT, APTT, t-PA, D-dimer, ETP, CRP, and white blood cell
(WBC) count. Neither PM1 nor coarse PM levels showed
associations with the difference between time 1 and time 2 in
PT, APTT, t-PA, D-dimer, ETP, CRP, or WBC count (data
not shown).
Table 1 Characteristics of the study population (n = 37)
Variable
Age [years (SD)] 42 (7)
Body mass index [kg m)2 (SD)] 266 (27)
Education categories, n (%)
Primary 10 (27)
Secondary 22 (59)
College 5 (14)
Current smokers, n (%) 18 (49)
Current cigarettes, n (SD) 12 (6)
Use of NSAIDs, n (%) 6 (16)
NSAID, non-steroidal anti-inﬂammatory drug; SD, standard deviation.
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To estimate permanent effects of PM, we ﬁtted mixed-
regression models on data that included the two repeated
measures of inﬂammation and blood coagulation markers,
regardless of whether they were measured on samples taken on
the ﬁrst day of work (time 1) or on those taken on the last day
of the working week (time 2) (Table 4). We found a signif-
icantly shorter PT in association with higher levels of coarse
PM () 0.33 s for an interquartile exposure increase,
P = 0.01), whereas the association with PM1 was not
statistically signiﬁcant () 0.33, P = 0.08). PM1 was signiﬁ-
cantly associated with increased t-PA (+ 0.72 ng mL)1,
P = 0.01) and ETP measured without exogenous triggers in
the presence of soluble thrombomodulin (+ 98.7 nM min,
P = 0.02). Coarse PM showed a signiﬁcant association with t-
PA (+ 0.88 ng mL)1, P = 0.04) and a borderline association
with ETP measured without exogenous triggers in the presence
of soluble thrombomodulin (+ 66.2 nM min, P = 0.05). No
PM effect was observed for ETP measured without exogenous
triggers and without thrombomodulin, or for ETP measured
with exogenous triggers (Table 4). CRP showed a positive
signiﬁcant correlation with levels of PM1 (+ 0.59 mg L
)1,
P = 0.03) and coarse PM (+ 0.48 mg L)1, P = 0.01). PM
exposures were not associated with APTT, D-dimer or WBC
count (Table 4).
Discussion
In the present study, based on a population of healthy workers
from a steel plant in northern Italy, we found that exposure to
PMdid not cause any rapid change in a panel of inﬂammation,
coagulation and ﬁbrinolysis markers, as reﬂected in the lack of
difference between measures obtained on blood samples
collected on the ﬁrst and last day of the same working week.
However, we showed that the levels of PM exposure were
Table 3 Blood coagulation and inﬂammation-related markers measured
in male foundry workers (n = 37) on the ﬁrst working day (time 1) and
the last working day (time 2, after three consecutive days of work) of a 4-
day working week
Outcomes
Mean (SD)
P-value
(paired t-test)
First day
(time 1)
Last day
(time 2)
PT (s) 11.2 (0.8) 11.2 (0.9) 0.25
APTT (s) 29.0 (2.4) 29.2 (2.5) 0.28
t-PA antigen (ng mL)1) 7.3 (4.2) 7.5 (4.4) 0.52
D-dimer (ng dL)1) 150 (63) 149 (70) 0.89
ETP TM+ (nM min)* 474 (283) 451 (332) 0.62
ETP TM) (nM min)* 791 (444) 780 (442) 0.87
ETP TM+ (nM min) 782 (315) 796 (316) 0.68
ETP TM) (nM min) 1486 (290) 1496 (293) 0.79
CRP (mg L)1) 1.5 (1.6) 1.4 (1.4) 0.41
WBCs (1000 mm)3) 7.3 (1.5) 7.2 (1.4) 0.67
APTT, activated partial thromboplastin time; CRP, C-reactive pro-
tein; ETP, endogenous thrombin potential; PT, prothrombin time; SD,
standard deviation; t-PA, tissue-type plasminogen activator; WBC,
white blood cell. *ETP measured without exogenous triggers and with
(TM+) or without (TM)) thrombomodulin. ETP measured with
exogenous triggers and with (TM+) or without (TM)) thrombo-
modulin.
Table 2 Individual exposure to PM10, PM1 and coarse PM (PM10 – PM1) (n = 37)
Particle concentration Mean (SD) Median IQR Minimum Maximum
PM10 (lg m
)3) 262 (272) 159 110–306 74 1220
PM1 (lg m
)3) 8.0 (7.7) 3.6 2.9–11 1.7 30.5
Coarse PM (lg m)3)* 254 (265) 162 106–293 71 1190
IQR, interquartile range; PM, particulate matter; SD, standard deviation. *Coarse PM was calculated by subtracting PM1 from PM10 exposure
levels.
Table 4 Association of particulate matter (PM) exposure with blood coagulation and inﬂammation-related markers – repeated-measure models
Outcomes
PM1 Coarse PM
Adjusted b SE P-value Adjusted b SE P-value
PT (s) ) 0.33 0.19 0.08 ) 0.33 0.13 0.01
APTT (s) ) 0.25 0.53 0.63 ) 0.06 0.39 0.87
t-PA antigen (ng mL)1) + 0.72 0.28 0.01 + 0.88 0.43 0.04
D-dimer (ng dL)1) ) 16.7 13.0 0.20 ) 16.0 9.4 0.09
ETP TM+ (nM min)* + 98.6 46.7 0.02 + 66.2 34.6 0.05
ETP TM) (nM min)* + 91.3 75.9 0.25 + 63.2 59.4 0.29
ETP TM+ (nM min) + 72.6 58.1 0.21 + 68.4 42.5 0.11
ETP TM) (nM min) + 25.7 49.5 0.60 + 32.6 36.4 0.37
CRP (mg L)1) + 0.59 0.27 0.03 + 0.48 0.20 0.01
WBC (1000 mm)3) ) 0.18 0.24 0.45 + 0.04 0.18 0.83
APTT, activated partial thromboplastin time; CRP, C-reactive protein; ETP, endogenous thrombin potential; PT, prothrombin time; SE, standard
error; t-PA, tissue-type plasminogen activator; WBC, white blood cell. *ETP measured without exogenous triggers and with (TM+) or without
(TM)) thrombomodulin. ETP measured with exogenous triggers and with (TM+) or without (TM)) thrombomodulin. Regression coeﬃcients
estimating the eﬀect associated with an interquartile range in PM1 or coarse PM, adjusted for age, body mass index, current smoking, education
and non-steroidal anti-inﬂammatory drug use in the 7 days before blood drawing.
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associated with higher systemic inﬂammation, as reﬂected in
increased circulating CRP, as well as shorter PT, increased
thrombin generation measured in the absence of exogenous
triggers and in the presence of soluble thrombomodulin, and
higher t-PA level. No exposure-related associations were found
for the other parameters.
The association of PM levels with coagulation markers and
CRP was observed in our study only when the two measure-
ments taken before (time 1) and after (time 2) three consecutive
working days were both included in repeated-measure models.
In these models, the effects on the two time points were
assumed to be similar [27]. This ﬁnding, together with the
absence of differences between the ﬁrst and last day of the same
working week, suggests that PM operated over an extended
timeframe, possibly causing a persistent hypercoagulable state
that was not reset to baseline over the 2 days between
consecutive working weeks.
The association of PM exposure levels with shortened PT
in the present study is consistent with the ﬁndings of a
previous investigation on ambient air pollution based on
healthy volunteers, in which we showed a moderate decrease
in PT in association with PM10 exposure [11]. Ambient and
occupational PM are clearly two different conditions of
exposure, so our results cannot be extrapolated to the general
population. However, our ﬁndings indicate some common
mechanisms that may be activated by the two different
exposures. Ambient PM exposure has been shown to elicit
systemic inﬂammation [6], which might represent a primary
mechanism for its prothrombotic outcomes [2,11,28]. The
ﬁnding of an association between PM exposure and CRP in
the present study points to inﬂammation as a potential
intermediate process that may contribute to modifying
coagulability [7].
ETP is deﬁned as the total amount of thrombin that is
generated in plasma in vitro, and increased levels have been
proposed as an index of hypercoagulability [22,23]. In the
present study, increased levels of ETP were associated with PM
exposure only when the test was performed without the
addition of exogenous triggers to the assay system. These
ﬁndings suggest that PM exposure may induce the release of
small amounts of endogenous tissue factor and/or negatively
charged phospholipids that may function as triggers of
thrombin formation in the assay system. The relatively high
concentrations reached in the assay system following the
addition of exogenous triggers do presumably blunt the effect
of PM-induced increases in the endogenous triggers. Evidence
has been provided that endogenous triggers of coagulation
(tissue factor and negatively charged phospholipids) may be
disseminated into the bloodstreamby circulatingmicroparticles
stemming from platelets and/or activated monocytes [29], thus
supporting our ﬁndings. A limitation of our study is that,
because of limitations in the quantity of plasma collected, we
could not perform any direct measurements of endogenous
coagulation triggers.
The thrombin generation assay employed in this study was
run with or without thrombomodulin. Thrombomodulin is the
main physiologic activator of protein C [30]; it is located on
endothelial cells, but not in plasma. Thus, the addition of
thrombomodulin to the assay system makes the assay able to
mimic much more than any other test the conditions existing
in vivo. The ratio between the values of the thrombin gener-
ation parameter ETP measured with and without thrombo-
modulin may be regarded as an index of the ability of
thrombomodulin to efﬁciently activate protein C. Accordingly,
plasmas displaying high ratios may be regarded as resistant to
the action of thrombomodulin, and are therefore associated
with hypercoagulability [31]. Increased ETP was associated
with PM concentrations when the assay was performed in the
presence, but not in the absence, of thrombomodulin. This
ﬁnding suggests that PM exposure makes plasma resistant to
the action of thrombomodulin as a protein C activator.
One limitation of our study is that thrombin generation was
measured without the addition to plasma of corn trypsin
inhibitor (CTI), which is known to quench contact coagulation
factor activation [32]. In the absence of CTI, thrombin
generation might be induced by tissue factor, but also by the
variable in vitro contact factor activation[32]. It is, however,
likely that the purported contact factor activation (if any)
would affect the investigated population throughout the entire
period of exposure to PM, thus leaving unaltered the conclu-
sion of this study.
Our ﬁnding of a PM-dependent elevation of t-PA antigen
indicates a reduced rather than heightened ﬁbrinolytic
activity, because the immunoassay of t-PA measures, to a
large extent, the circulating complexes between t-PA and the
main ﬁbrinolysis inhibitor plasminogen activator inhibitor-1
[32], and thus also reﬂects a condition of systemic inﬂam-
mation.
In our study, we had the advantage of contrasting subjects
with a wide range of exposure levels, owing to the differences
in PM levels in the different job positions across the work
facility. Our study did not include an external reference
population of individuals without occupational exposure to
PM. However, the lowest PM exposure observed in our
study (PM1 = 1.7 lg m
)3, PM10 = 74 lg m
)3) was rela-
tively low, particularly if compared with the highest level
found in our population (PM1 = 30.5 lg m
)3, PM10 =
1220 lg m)3). In addition, the lowest PM exposure in our
study was only marginally higher than ambient PM levels
measured in the geographic area in which the plant is located
(average annual ambient PM10 levels between 41 and
57 lg m)3 were recorded by ambient monitoring stations in
the Brescia area [33]). Therefore, although we did not have
an external control group, the wide range of exposure makes
it possible to consider the subjects in our study with lower
exposures as an internal control group. The regression
analysis that we used takes full advantage of the extended
range of exposures. In addition, it is worth noting that
limiting our investigation to individuals who had all been
working in the same work facility avoided potential concerns
related to the selection of external referents who might
have differed from the exposed population in terms of
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socioeconomic factors and other characteristics determining
hiring into the plant [34].
A further limitation of our study was that individual
exposure to PM was based on measures obtained during
only one working week. Differences in previous job tasks
could have caused misclassiﬁcation of individual exposure.
The study population, however, included workers assigned to
speciﬁc job tasks repeated regularly every day and who had
been employed in the plant for at least 1 year, thus ensuring
that the exposure measures used represented the usual
ambient exposure of each individual. This was also conﬁrmed
by the high correlation between measures of PM exposure
obtained 1 year apart from each other for a subset of
subjects. In our study, both coarse particles and PM1 were
associated with inﬂammation and coagulation markers.
Because of the strong correlation between coarse and PM1
personal exposure, our study did not have enough statistical
power to identify which portion of PM is the determinant of
the effects observed. In addition to PM, workers in foundries
may have other exposures, including polycyclic aromatic
hydrocarbons [35], carbon monoxide [36], and non-ionizing
radiation [37]. Although the participants in our study were in
a modern facility with state-of-the-art systems for chemical
and physical exposure reduction, we cannot exclude the
possibility that these exposures might have contributed to the
observed associations.
It is important to note that, although our study showed
moderate changes in the average levels of coagulation,
inﬂammation and ﬁbrinolysis markers, none of the subjects
showed clinically relevant alterations. Thus, we have no
evidence of increased cardiovascular risk among healthy
workers exposed to PM levels like the ones we found in this
modern steel plant.
In conclusion, our study did not show any change in
inﬂammation and coagulation markers when we contrasted
measures obtained on the last day of aworkingweekwith those
taken on the ﬁrst day of the same working week. However, the
ﬁnding that PM exposure levels were associated with moderate
changes in PT, thrombin generation and t-PA provides some
evidence that PM-induced systemic inﬂammation, as also
reﬂected in the positive association of PM with plasma CRP,
may enhance blood coagulation.
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